Autoimmune Pancreatitis: CT Patterns and Their Changes after Steroid Treatment
- 1 May 2008
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 247 (2) , 435-443
- https://doi.org/10.1148/radiol.2472070598
Abstract
To retrospectively evaluate the computed tomographic (CT) patterns of autoimmune pancreatitis (AIP) and their changes after steroid therapy.Investigational review board approval was obtained, and the informed consent requirement was waived. The medical and imaging data of 21 patients (13 men, eight women; mean age, 47.5 years; age range, 25-79 years) with histopathologically proved AIP who underwent contrast material-enhanced CT at diagnosis and after steroid treatment were included in this study. Image analysis included assessment of the (a) presence or absence and type (focal or diffuse) of pancreatic parenchyma enlargement, (b) contrast enhancement of pancreatic parenchyma, (c) size of the main pancreatic duct (MPD) within the lesion and upstream, and (d) pancreatic parenchyma thickness in the head, body, and tail of the pancreas. The same criteria were applied to follow-up CT examinations, the follow-up data were compared with pretreatment data, and a paired sample t test was applied.Pancreatic parenchyma showed focal enlargement in 14 (67%) patients and diffuse enlargement in seven (33%). Pancreatic parenchyma affected by AIP appeared hypoattenuating in 19 (90%) patients and isoattenuating in two (10%). During the portal venous phase, pancreatic parenchyma showed contrast material retention in 18 (86%) patients and contrast material washout in three (14%). The MPD was never visible within the lesion. After treatment, there was a reduction in the size of pancreatic parenchyma segments affected by AIP (P < .05). Fifteen (71%) of the 21 patients had a normal enhancement pattern in the pancreatic parenchyma, whereas the enhancement pattern remained hypovascular in six (29%). The MPD returned to its normal size within the lesion in all patients at follow-up CT. In one of the eight patients with focal forms of AIP, the upstream MPD remained dilated.AIP appeared as pancreatic parenchyma enlargement, with MPD stenosis within the lesion and upstream dilatation in focal forms of AIP. After steroid treatment, there was normalization of these findings.Keywords
This publication has 22 references indexed in Scilit:
- Autoimmune pancreatitisDigestive and Liver Disease, 2005
- Autoimmune pancreatitisJournal of Gastrointestinal Surgery, 2005
- Autoimmune Pancreatitis Is A Systemic Autoimmune DiseaseAmerican Journal of Gastroenterology, 2003
- Autoimmune related pancreatitisGut, 2002
- Autoimmune-related pancreatitisCurrent Treatment Options in Gastroenterology, 2001
- "Non-alcoholic duct destructive chronic pancreatitis" or "primary chronic pancreatitis"?Gut, 1999
- Autoimmune Pancreatitis as a New Clinical Entity (Three Cases of Autoimmune Pancreatitis with Effective Steroid Therapy)Digestive Diseases and Sciences, 1997
- Chronic pancreatitis caused by an autoimmune abnormalityDigestive Diseases and Sciences, 1995
- Sclerosing cholangitis, chronic pancreatitis, and sjogren's syndrome: A syndrome complexThe American Journal of Surgery, 1984
- Primary Sclerosing Cholangitis Associated with Fibrosis of the Submandibular Glands and the PancreasActa Medica Scandinavica, 1979